The American Institute of Ultrasound in Medicine (AIUM) is a multidisciplinary association dedicated to advancing the safe and effective use of ultrasound in medicine through professional and public education, research, development of guidelines, and accreditation. To promote this mission, the AIUM is pleased to publish in conjunction with the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal-Fetal Medicine (SMFM), and the American Society of Echocardiography (ASE) this AIUM Practice Guideline for the Performance of Fetal Echocardiography. Additionally, this guideline is endorsed by the American College of Radiology (ACR).
The AIUM represents the entire range of clinical and basic science interests in medical diagnostic ultrasound, and, with hundreds of volunteers, this multidisciplinary organization has promoted the safe and effective use of ultrasound in clinical medicine for more than 50 years. This document and others like it will continue to advance this mission.
Practice guidelines of the AIUM are intended to provide the medical ultrasound community with guidelines for the performance and recording of high-quality ultrasound examinations. The guidelines reflect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the guidelines with recognition that deviations from these guidelines will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the guidelines to provide additional service and information as needed.
The clinical aspects contained in specific sections of this practice guideline (Introduction, Indications, Specifications of the Examination, and Equipment Specifications) have been developed by the AIUM, ACR, ACOG, SMFM, and ASE. 14750 Sweitzer Ln, Suite 100 Laurel, MD 20707-5906 USA 800-638-5352 • 301-498-4100 www.aium.org
I. Introduction
Congenital heart disease is a leading cause of infant morbidity and mortality from birth defects with an estimated incidence of 6 per 1000 live births for moderate to severe forms.
1,2 Accurate prenatal diagnosis offers potential clinical benefit with regard to infant outcome, especially in those cases that are likely to require prostaglandin infusion to maintain patency of the ductus arteriosus.
3-5 Fetal echocardiography is broadly defined as a detailed sonographic evaluation that is used to identify and characterize fetal heart anomalies before delivery. This specialized diagnostic procedure is an extension of the "basic" and "extended basic" fetal cardiac screening guidelines that have been previously described for the 4-chamber view and outflow tracts.
6,7
It should be performed only when there is a valid medical reason, and the lowest possible ultrasonic exposure settings should be used to gain the necessary diagnostic information. While it is not possible to detect every abnormality, adherence to the following guideline will maximize the probability of detecting most cases of clinically significant congenital heart disease.
II. Qualifications and Responsibilities of Personnel
Performance and interpretation of fetal echocardiography require a unique set of advanced skills and knowledge. Specific training requirements and maintenance of competency guidelines have been developed by the AIUM 8,9 as well as the ASE in conjunction with the American Heart Association, the American College of Cardiology, and the American Academy of Pediatrics. 10, 11 Appropriately trained obstetricians, maternal-fetal medicine specialists, pediatric cardiologists, and radiologists with special expertise in fetal imaging who have acquired the appropriate knowledge base and skills as outlined in these statements may perform fetal echocardiography.
III. Indications
Indications for fetal echocardiography are often based on a variety of parental and fetal risk factors for congenital heart disease. 12, 13 However, most cases are not associated with known risk factors. Common indications for a detailed scan of the fetal heart include but are not limited to the following: 
IV. Written Request for the Examination
The written or electronic request for an ultrasound examination should provide sufficient information to allow for the appropriate performance and interpretation of the examination.
A request for the examination must be originated by a physician or other appropriately licensed health care provider or under the provider's direction. The accompanying clinical information should be provided by a physician or other appropriate health care provider familiar with the patient's clinical situation and should be consistent with relevant legal and local health care facility requirements.
V. Specifications of the Examination
The following section describes required and optional elements for fetal echocardiography.
A. General Considerations
Fetal echocardiography is commonly performed between 18 and 22 weeks' gestational age. Some forms of congenital heart disease may even be recognized during earlier stages of pregnancy. 14 Optimal views of the heart are usually obtained when the cardiac apex is directed toward the anterior maternal wall. Technical limitations (eg, maternal obesity, prone fetal position, and late gestation) can make a detailed heart evaluation very difficult due to acoustic shadowing, especially during the third trimester. It may be necessary to examine the patient at a different time if the heart is poorly visualized. The examiner can optimize sonograms by appropriate adjustment of technical settings, such as acoustic focus, frequency selection, signal gain, image magnification, temporal resolution, harmonic imaging, and Doppler-related parameters (eg, velocity scale, frequency wall filter, and frame rate). Because the heart is a dynamic structure, a complete evaluation can only be made if real-time imaging with acquisition of analog recordings or digital video clips is used as a standard part of every fetal echocardiogram.
B. Cardiac Imaging Parameters: Basic Approach
The fetal echocardiogram is a detailed evaluation of cardiac structure and function. This method typically involves a sequential segmental analysis of 3 basic areas that include the atria, ventricles, and great arteries and their connections.
15-17 A segmental analysis includes an initial assessment of fetal right/left orientation, followed by an assessment of the following segments and their relationships:
• Visceral/abdominal situs:
ο Stomach position; and ο Cardiac apex position;
• Atria: ο Situs; ο Systemic and pulmonary venous connections; ο Venous anatomy; and ο Atrial anatomy (including septum);
• Ventricles: ο Position; ο Atrial connections; ο Ventricular anatomy (including septum); ο Relative and absolute size; ο Function; and ο Pericardium; and
• Great arteries (aorta, main and branch pulmonary arteries, and ductus arteriosus): ο Position relative to the trachea; ο Ventricular connections; and ο Vessel size, patency, and flow (both velocity and direction).
In addition to a segmental analysis, the following connections should be evaluated:
• Atrioventricular junction: anatomy, size, and function of atrioventricular (eg, mitral and tricuspid) valves; and • Ventriculoarterial junction: anatomy, size, and function of semilunar (eg, aortic and pulmonary) valves, including assessment of both the subpulmonary and subaortic regions.
C. Grayscale Imaging (Required)
Key scanning planes can provide useful diagnostic information about the fetal heart (Figures 1-3) . [18] [19] [20] [21] [22] [23] Evaluation should include the following criteria, noting abnormalities of the heart and pericardium: 
E. Heart Rate and Rhythm Assessment
Documentation of the heart rate and rhythm should be made by cardiac cycle length measurements obtained by the Doppler technique or M-mode interrogation. A normal fetal heart rate at mid-gestation is 120 to 180 beats per minute. If bradycardia or tachycardia is documented, or if the rhythm is noted to be irregular, simultaneous assessment of atrial and ventricular contraction should be performed using either simultaneous Doppler sonography of the mitral inflow-aortic outflow or superior vena cava-ascending aorta or by M-mode sonography of the atrium and ventricle to determine the underlying mechanism. An alternative approach using tissue Doppler sonography of the atrium and ventricle has also been described. Right and left heart function should be qualitatively assessed in all studies. Signs of cardiomegaly, atrioventricular valve regurgitation, and hydrops fetalis should be noted. If abnormal ventricular function is suspected, quantitative assessment of heart function should be considered and can include measures such as fractional shortening, 36 ventricular strain, 37, 38 and the myocardial performance index.
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H. Complementary Imaging Strategies (Optional)
Other adjunctive imaging modalities, such as 3-and 4-dimensional sonography, have been used to evaluate anatomic defects and to quantify fetal hemodynamic parameters, such as cardiac output. [43] [44] [45] [46] Adjunctive Doppler modalities that have been used include tissue and continuous wave Doppler.
47-50
VI. Reporting and Documentation
Adequate documentation is essential for high-quality patient care. There should be a permanent record of the fetal echocardiographic examination and its interpretation. 
VII. Equipment Specifications
A sonographic examination of the fetal heart should be conducted using a real-time scanner. Sector, curvilinear, and endovaginal transducers are used for this purpose. The transducer or scanner should be adjusted to operate at the highest clinically appropriate frequency, realizing that there is a trade-off between resolution and beam penetration. With modern equipment, fetal imaging studies performed from the anterior abdominal wall can usually use frequencies of 5.0 MHz or higher, whereas scans performed from the vagina should be performed using frequencies of 7 MHz or higher. Acoustic shadowing and maternal body habitus may limit the ability of higher-frequency transducers from providing greater anatomic detail for the fetal heart. 
VIII. Quality Control and
